The role of bioactive glass in the management of chronic osteomyelitis: a systematic review of literature and current evidence

References

• Kremers HM, Nwojo ME, Ransom JE, et al. Trends in the epidemiology of osteomyelitis. J Bone Joint Surg Am. 2015;97(10):837–845.
   PubMed Web of Science ®Google Scholar
• Cierny G, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res. 2003;414:7–24.
   Web of Science ®Google Scholar
• Walter G, Kemmerer M, Kappler C, et al. Treatment algorithms for chronic osteomyelitis. Dtsch Aerzteblatt Int. 2012;109(14):257–264.
   PubMed Web of Science ®Google Scholar
• Parsons B, Strauss E. Surgical management of chronic osteomyelitis. Am J Surg. 2004;188(1):57–66.
   PubMedGoogle Scholar
• Schlickewei CW, Yarar S, Rueger JM. Eluting antibiotic bone graft substitutes for the treatment of osteomyelitis in long bones. A review: evidence for their use? Orthop Res Rev. 2014;6:71–79.
   Google Scholar
• Xing J, Hou T, Luobu B, et al. Anti-infection tissue engineering construct treating osteomyelitis in rabbit tibia. Tissue Eng A. 2013;19(1–2):255–263.
   PubMed Web of Science ®Google Scholar
• Karr JC, Lauretta J, Keriazes G. In vitro antimicrobial activity of calcium sulfate and hydroxyapatite (cerament bone void filler) discs using heat-sensitive and non-heat-sensitive antibiotics against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. J Am Podiatr Med Assoc. 2011;101(2):146.
   PubMed Web of Science ®Google Scholar
• Greenspan DC. Glass and medicine: the Larry Hench Story. Int J Appl Glass Sci. 2016;7(2):134–138.
   Web of Science ®Google Scholar
• Fiume E, Barberi J, Verné E, et al. Bioactive glasses: from parent 45S5 composition to scaffold-assisted tissue-healing therapies. J Funct Biomater. 2018;9(1).
   PubMed Web of Science ®Google Scholar
• Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.1.0; 2011. West Sussex: Wiley.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. PRISMA 2009 flow diagram. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis. 2005;9(3):127–138.
   PubMed Web of Science ®Google Scholar
• Malat TA, Glombitza M, Dahmen J, et al. The use of bioactive glass S53P4 as bone graft substitute in the treatment of chronic osteomyelitis and infected non-unions – a retrospective study of 50 patients. Z Orthop Unfall. 2018;156(2):152–159.
   PubMed Web of Science ®Google Scholar
• Ferrando A, Part J, Baeza J. Treatment of cavitary bone defects in chronic osteomyelitis: bioactive glass S53P4 vs. calcium sulphate antibiotic beads. J Bone Jt Infect. 2017;2(4):194–201.
   PubMedGoogle Scholar
• Stoor P, Apajalahti S, Kontio R. Regeneration of cystic bone cavities and bone defects with bioactive glass S53P4 in the upper and lower jaws. J Craniofac Surg. 2017;28(5):1197–1205.
   PubMed Web of Science ®Google Scholar
• Lindfors N, Geurts J, Drago L, et al. Antibacterial bioactive glass, S53P4, for chronic bone infections – a multinational study. Adv Exp Med Biol. 2017;971:81–92.
   PubMed Web of Science ®Google Scholar
• Romanò CL, Logoluso N, Meani E, et al. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study. Bone Jt J. 2014;96-B(6):845–850.
   PubMedGoogle Scholar
• Drago L, Romanò D, De Vecchi E, et al. Bioactive glass bag-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study. BMC Infect Dis. 2013;13(1):584.
   PubMed Web of Science ®Google Scholar
• McAndrew J, Efrimescu C, Sheehan E, et al. Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis. Ir J Med Sci. 2013;182(3):509–511.
   PubMed Web of Science ®Google Scholar
• Lindfors NC, Hyvönen P, Nyyssönen M, et al. Bioactive glass S53P4 as a bone graft substitute in the treatment of osteomyelitis. Bone. 2010;47(2):212–218.
   PubMed Web of Science ®Google Scholar
• Zitko D, Urban K. Bioactive glass-ceramic ATB carrier treatment of chronic osteomyelitis. Acta Chir Orthop Traumatol Cech. 1998;65(4):231–237.
   PubMedGoogle Scholar
• Geurts JTV, Gabriels F, Arts JJ, et al. P. Contemporary treatment of chronic osteomyelitis: implementation in low- and middle-income countries. SA Orthop J. 2018;17(2):40–43.
   Google Scholar
• Ordoñez S, Molano J. Bioactive glass S53P4 in treatment of osteomyelitis: a report of 6 clinical cases. Abstracts from the 6th IFFAS Triennial Meeting. Foot Ankle Surg. 2017;23(S1):29–154.
   Google Scholar
• Godoy-Santos AL, Rosemberg LA, de Cesar-Netto C, et al. The use of bioactive glass S53P4 in the treatment of an infected Charcot foot: a case report. J Wound Care. 2019;28(Suppl. 1):S14–S17.
   PubMed Web of Science ®Google Scholar
• Kankare J, Lindfors NC. Reconstruction of vertebral bone defects using an expandable replacement device and bioactive glass S53P4 in the treatment of vertebral osteomyelitis: three patients and three pathogens. Scand J Surg. 2016;105(4):248–253.
   PubMed Web of Science ®Google Scholar
• De Giglio R, Stefani I, Mondello T, et al. BIOACTIVE GLASS S53P4: a new opportunity for the treatment in the diabetic foot osteomyelitis. Eur J Intern Med. 2018;54:e15–e16.
   PubMed Web of Science ®Google Scholar
• van Gestel NAP, Geurts J, Hulsen DJW, et al. Clinical applications of S53P4 bioactive glass in bone healing and osteomyelitic treatment: a literature review. Biomed Res Int. 2015;2015:1.
   Google Scholar
• Aurégan JC, Bégué T. Bioactive glass for long bone infection: a systematic review. Injury. 2015;46(Suppl. 8):S3–S7.
   PubMedGoogle Scholar
• Drago L, Toscano M, Bottagisio M. Recent evidence on bioactive glass antimicrobial and antibiofilm activity: a mini-review. Materials. 2018;11(2):326.
   Web of Science ®Google Scholar
• Geurts J, Vranken T, Arts JJC. Treatment of osteomyelitis by means of bioactive glass-initial experience in the Netherlands. Ned Tijdschr Voor Orthop. 2016;23:37–41.
   Google Scholar
• McPherson EJ, Woodson C, Holtom P, et al. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res. 2002;403:8–15.
   PubMed Web of Science ®Google Scholar
• Day RM. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng. 2005;11(5–6):768–777.
   PubMedGoogle Scholar
• Keshaw H, Forbes A, Day RM. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials. 2005;26(19):4171–4179.
   PubMed Web of Science ®Google Scholar
• Xynos ID, Edgar AJ, Buttery LDK, et al. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun. 2000;276(2):461–465.
   PubMed Web of Science ®Google Scholar